These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 26160324)

  • 41. Remnant lipoproteins and atherogenesis.
    Kawakami A; Yoshida M
    J Atheroscler Thromb; 2005; 12(2):73-6. PubMed ID: 15942116
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Characterization of a hypertriglyceridemic transgenic miniature pig model expressing human apolipoprotein CIII.
    Wei J; Ouyang H; Wang Y; Pang D; Cong NX; Wang T; Leng B; Li D; Li X; Wu R; Ding Y; Gao F; Deng Y; Liu B; Li Z; Lai L; Feng H; Liu G; Deng X
    FEBS J; 2012 Jan; 279(1):91-9. PubMed ID: 22023023
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The emerging role of apolipoprotein C-III: beyond effects on triglyceride metabolism.
    Luo M; Peng D
    Lipids Health Dis; 2016 Oct; 15(1):184. PubMed ID: 27770802
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Triglyceride-rich lipoproteins and cardiovascular diseases.
    Xu D; Xie L; Cheng C; Xue F; Sun C
    Front Endocrinol (Lausanne); 2024; 15():1409653. PubMed ID: 38883601
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Apolipoprotein C-III: understanding an emerging cardiovascular risk factor.
    Ooi EM; Barrett PH; Chan DC; Watts GF
    Clin Sci (Lond); 2008 May; 114(10):611-24. PubMed ID: 18399797
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dietary-Induced Elevations of Triglyceride-Rich Lipoproteins Promote Atherosclerosis in the Low-Density Lipoprotein Receptor Knockout Syrian Golden Hamster.
    Lin X; Ma P; Yang C; Wang J; He K; Chen G; Huang W; Fan J; Xian X; Wang Y; Liu G
    Front Cardiovasc Med; 2021; 8():738060. PubMed ID: 34796210
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Production of apolipoprotein C-III knockout rabbits using zinc finger nucleases.
    Yang D; Zhang J; Xu J; Zhu T; Fan Y; Fan J; Chen YE
    J Vis Exp; 2013 Nov; (81):e50957. PubMed ID: 24301055
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Apolipoproteins E and CIII interact to regulate HDL metabolism and coronary heart disease risk.
    Morton AM; Koch M; Mendivil CO; Furtado JD; Tjønneland A; Overvad K; Wang L; Jensen MK; Sacks FM
    JCI Insight; 2018 Feb; 3(4):. PubMed ID: 29467335
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Subendothelial retention of atherogenic lipoproteins in early atherosclerosis.
    Skålén K; Gustafsson M; Rydberg EK; Hultén LM; Wiklund O; Innerarity TL; Borén J
    Nature; 2002 Jun; 417(6890):750-4. PubMed ID: 12066187
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Emerging Evidence that ApoC-III Inhibitors Provide Novel Options to Reduce the Residual CVD.
    Taskinen MR; Packard CJ; Borén J
    Curr Atheroscler Rep; 2019 May; 21(8):27. PubMed ID: 31111320
    [TBL] [Abstract][Full Text] [Related]  

  • 51. ApoCIII enrichment in HDL impairs HDL-mediated cholesterol efflux capacity.
    Luo M; Liu A; Wang S; Wang T; Hu D; Wu S; Peng D
    Sci Rep; 2017 May; 7(1):2312. PubMed ID: 28539597
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Triglyceride-rich lipoprotein metabolism in unique VLDL receptor, LDL receptor, and LRP triple-deficient mice.
    Espirito Santo SM; Rensen PC; Goudriaan JR; Bensadoun A; Bovenschen N; Voshol PJ; Havekes LM; van Vlijmen BJ
    J Lipid Res; 2005 Jun; 46(6):1097-102. PubMed ID: 15772433
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Association of the S2 allele of the SstI polymorphism in the apoC3 gene with plasma apoCIII interacts with unfavorable lipid profiles to contribute to atherosclerosis in the Li ethnic group in China.
    Sun M; Chen L; Liu H; Ma L; Wang T; Liu Y
    Lipids Health Dis; 2017 Nov; 16(1):220. PubMed ID: 29162127
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In the Beginning, Lipoproteins Cross the Endothelial Barrier.
    Goldberg IJ; Cabodevilla AG; Younis W
    J Atheroscler Thromb; 2024 Jun; 31(6):854-860. PubMed ID: 38616110
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Large triglyceride-rich lipoproteins in hypertriglyceridemia are associated with the severity of acute pancreatitis in experimental mice.
    Zhang Y; He W; He C; Wan J; Lin X; Zheng X; Li L; Li X; Yang X; Yu B; Xian X; Zhu Y; Wang Y; Liu G; Lu N
    Cell Death Dis; 2019 Sep; 10(10):728. PubMed ID: 31570698
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Apolipoprotein C3: form begets function.
    Bornfeldt KE
    J Lipid Res; 2024 Jan; 65(1):100475. PubMed ID: 37972731
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Interleukin-10 deficiency increases atherosclerosis, thrombosis, and low-density lipoproteins in apolipoprotein E knockout mice.
    Caligiuri G; Rudling M; Ollivier V; Jacob MP; Michel JB; Hansson GK; Nicoletti A
    Mol Med; 2003; 9(1-2):10-7. PubMed ID: 12765335
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hypertriglyceridemia and Atherosclerosis: Using Human Research to Guide Mechanistic Studies in Animal Models.
    Basu D; Bornfeldt KE
    Front Endocrinol (Lausanne); 2020; 11():504. PubMed ID: 32849290
    [TBL] [Abstract][Full Text] [Related]  

  • 59. ApoCIII-enriched LDL in type 2 diabetes displays altered lipid composition, increased susceptibility for sphingomyelinase, and increased binding to biglycan.
    Hiukka A; Ståhlman M; Pettersson C; Levin M; Adiels M; Teneberg S; Leinonen ES; Hultén LM; Wiklund O; Oresic M; Olofsson SO; Taskinen MR; Ekroos K; Borén J
    Diabetes; 2009 Sep; 58(9):2018-26. PubMed ID: 19502413
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Overexpression of 15-lipoxygenase in vascular endothelium accelerates early atherosclerosis in LDL receptor-deficient mice.
    Harats D; Shaish A; George J; Mulkins M; Kurihara H; Levkovitz H; Sigal E
    Arterioscler Thromb Vasc Biol; 2000 Sep; 20(9):2100-5. PubMed ID: 10978255
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.